gptkbp:instance_of
|
gptkb:healthcare_organization
|
gptkbp:affects
|
gptkb:watch
|
gptkbp:associated_with
|
Lewy bodies
|
gptkbp:caused_by
|
loss of dopamine-producing neurons
|
gptkbp:complications
|
gptkb:historical_event
sleep disorders
cognitive impairment
autonomic dysfunction
|
gptkbp:famous_person
|
gptkb:Billy_Graham
gptkb:Muhammad_Ali
gptkb:Terry_Jones
gptkb:Pope_John_Paul_II
gptkb:Michael_J._Fox
|
gptkbp:first_described_by
|
gptkb:James_Parkinson
|
gptkbp:genetic_diversity
|
familial Parkinson's disease
|
https://www.w3.org/2000/01/rdf-schema#label
|
Parkinson's
|
gptkbp:is_involved_in
|
gptkb:Michael_J._Fox_Foundation
gptkb:Davis_Phinney_Foundation
gptkb:Parkinson's_Foundation
|
gptkbp:is_popular_in
|
1% of the population over 60
|
gptkbp:number_of_stages
|
early stage
advanced stage
middle stage
|
gptkbp:research_areas
|
gptkb:physicist
biomarkers
clinical trials
neuroprotective agents
stem cell therapy
|
gptkbp:research_focus
|
neurodegeneration
|
gptkbp:risk_factor
|
gptkb:physicist
age
environmental toxins
|
gptkbp:social_responsibility
|
neurological examination
typically diagnosed in 60s
|
gptkbp:symptoms
|
fatigue
pain
constipation
rigidity
tremors
urinary problems
bradykinesia
postural instability
loss of sense of smell
|
gptkbp:treatment
|
gptkb:hospital
gptkb:deep_brain_stimulation
gptkb:drug
physical therapy
dietary changes
exercise programs
medication adjustments
|
gptkbp:bfsParent
|
gptkb:Parkinson's_Disease
|
gptkbp:bfsLayer
|
6
|